The implementation of AIDRSS offers transformative implications for DR screening in India, particularly in rural and ...

Data from various retinal clinical trials suggest that there is a difference in efficacy in anti-VEGF therapies for patients with lower vision, according to a speaker here. During a presentation at ...

Highlighting the event is the immersive simulation, “Seeing Beyond the Ordinary and Repairing Damages,” led by world-renowned ...

The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was well tolerated.

The collaboration will focus on preventive solutions, workshops, and public awareness. King Faisal Specialist Hospital and ...

The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...

Whether you have known vision issues or not, there are several reasons why it's important to prioritize your eye health, as your vision has implications for the health of your body as a whole. Here, ...

Greg Ellwood-Hughes explores how AI is supporting ophthalmology services and the issues to be addressed in the coming years ...

As global markets show signs of optimism with cooling inflation and strong earnings reports, major U.S. stock indexes have rebounded, particularly favoring value stocks over growth shares. In this ...

US-based biotechnology company Ocugen has dosed the first subject in a multicentre Phase I trial of OCU200 for diabetic ...

Not available at this time. 1515 Aquarena Springs Drive, Ste. 105, San Marcos ...

In 2024, the FDA approved 19 biosimilars across various therapeutic areas, including the first biosimilars for ustekinumab ...